References
- D'Amico G, Pietrosi G, Tarantino I, Pagliaro L. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124: 1277–91
- Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the cardiovascular system part 1: receptor physiology. Crit Care 2003; 7: 427–34
- Forsling ML, Aziz LA, Miller M, Davies R, Donovan B. Conversion of triglycylvasopressin to lysine-vasopressin in man. J Endocrinol 1980; 85: 237–44
- Nadvornikova H, Schueck O. The influence of a single dose of vasopressin analogs on human renal potassium excretion. Int J Clin Pharmacol Ther Toxicol 1982; 20: 155–8
- Escorsell A, Ruiz del Arbol L, Planas R, Albillos A, Banares R, Cales P, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the test study. Hepatology 2000; 32: 471–6
- Douriez E, Mollard P, Laval C, Albengres E, Laporte JP, Tillment JP. Severe hyponatraemia after repeated IV administration of terlipressin [French]. Therapie 1993;48:518–9 ( transl. Hyponatraemia: case report. Reactions Weekly 1994;1:12).